RE:RE:RE:RE:Endo is our partner.........Exactly. But how does this explain their behaviour? why would the FDA *FAST-TRACK* it twice if they didn't see its potential? We didn't have ENDO when we submitted BLA and they STILL fast-tracked it. This doesn't make sense. They're trying to derail a treatment based on too narrow a scope